XBIRA ABIRATERONE ACETATE 250MG TABLETS

Get a Price/Quote

XBIRA ABIRATERONE ACETATE 250MG TABLETS Specification

Indication
Metastatic castration-resistant prostate cancer (mCRPC)

Origin of Medicine
India

Salt Composition
Abiraterone Acetate 250mg

Pacakaging (Quantity Per Box)
120 tablets per bottle

Dosage Form
Tablet

Drug Type
Allopathic

Ingredients
Abiraterone Acetate

Physical Form
Tablets

Function
Anti-cancer medication; androgen biosynthesis inhibitor

Recommended For
Prostate Cancer Patients

Dosage
250 mg per tablet

Dosage Guidelines
As prescribed by oncologist; typically 1000 mg (4 tablets) once daily on an empty stomach

Suitable For
Adults only (men)

Quantity
120 tablets per bottle

Storage Instructions
Store below 30C, protect from moisture and light

Prescription Required
Yes

Marketed By
Cipla Ltd.

Route of Administration
Oral

Container Type
Plastic bottle

Brand Name
XBIRA

Warnings
Not for use in women or children; use effective contraception; monitor liver function

Side Effects
Hypertension, hypokalemia, liver function abnormalities, joint swelling, hot flushes

Color
White to off-white film coated

Shelf Life
24 months from date of manufacture

XBIRA ABIRATERONE ACETATE 250MG TABLETS Trade Information

Packaging Details
PACK OF 28 TABLETS

Main Domestic Market
All India

About XBIRA ABIRATERONE ACETATE 250MG TABLETS

Xbira 250 Mg Abiraterone Acetate

Specifications:-

Brand Name: Xbira
Active Ingredients: Abiraterone Acetate
Manufactured by: Cipla
Strength: 250 mg
Packing : Pack of 120 Tablets

Note :- Xbira is a prescription Drug and should be used under Proper Medical Guidance and Advice. Do not share the medicine with others, since they may be suffering from a problem that is not effectively treated by this drug..............

How XBIRA Works Against Prostate Cancer

XBIRA contains abiraterone acetate, which belongs to the class of androgen biosynthesis inhibitors. By blocking an enzyme involved in androgen production, XBIRA helps reduce the growth-promoting effects of androgens on prostate cancer cells, resulting in delayed progression of metastatic castration-resistant prostate cancer (mCRPC) in men.

Proper Usage and Dosage Guidelines

XBIRA 250mg tablets should only be taken as prescribed by your oncologist, typically at a dose of 1000 mg (four tablets) once daily on an empty stomach. Each bottle contains 120 tablets, designed for adult male patients. Never adjust the dose without consulting your healthcare provider to ensure best therapeutic outcomes and safety.

Safety, Storage, and Side Effects

Store XBIRA tablets in their original plastic bottle at temperatures below 30C, protected from moisture and light. Common side effects include hypertension, low potassium, liver function abnormalities, joint swelling, and hot flushes. Regular monitoring of blood pressure and liver function is necessary. This medication is not suitable for women or children.

FAQs of XBIRA ABIRATERONE ACETATE 250MG TABLETS:

Q: What is XBIRA Abiraterone Acetate 250mg prescribed for?

A: XBIRA is prescribed for adult men diagnosed with metastatic castration-resistant prostate cancer (mCRPC) to inhibit the growth of cancer cells by blocking androgen biosynthesis.

Q: How should I take XBIRA tablets for best results?

A: Each tablet should be taken orally, as directed by your oncologist. The typical dose is 1000 mg (four 250mg tablets) once daily on an empty stomach. Follow your healthcare providers instructions closely for optimal effect.

Q: What measures should I take to store XBIRA safely?

A: Keep the tablets in the plastic bottle provided, store below 30C, and protect them from moisture and light to preserve effectiveness throughout the 24-month shelf life.

Q: Are there potential side effects when using XBIRA?

A: Common side effects include hypertension, hypokalemia (low potassium levels), liver function abnormalities, joint swelling, and hot flushes. Periodic monitoring of blood pressure and liver function is advised.

Q: Who should not use XBIRA Abiraterone Acetate tablets?

A: XBIRA is intended only for adult men and is not suitable for women or children. Women of childbearing potential should use effective contraception while handling the medication.

Q: How does XBIRA benefit prostate cancer patients?

A: By inhibiting androgen biosynthesis, XBIRA helps slow the progression of advanced prostate cancer, potentially improving survival and quality of life for patients with mCRPC.

Q: When is it necessary to consult a healthcare provider during treatment?

A: Immediate consultation is needed if you experience severe side effects or abnormal symptoms. Regular appointments are required to monitor blood pressure, liver function, and overall health during treatment.

Tell us about your requirement